Crystal structure of the cytoplasmic domain of the type I TGFβ receptor in complex with FKBP12

Cell

Volumn 96, Issue 3, 1999, Pages 425-436

  Huse, Morgan ^a   Chen, Ye Guang ^b   Massagué, Joan ^b   Kuriyan, John ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FK 506 BINDING PROTEIN; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 0033524943     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80555-3     Document Type: Article

References (61)

1. Armstrong, R.N., Kondo, H., Granot, J., Kaiser, E.T., and Mildvan, A.S. (1979). Magnetic resonance and kinetic studies of the manganese II ion and substrate complexes of the catalytic subunit of adenosine 3′,5′-monophosphate dependent protein kinasefrom bovine heart. Biochemistry 18, 1230-1238.
2. Brünger, A.T. (1992). The free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-474.
3. Brünger, A.T., Adams, P.D., Clore, G.M., Gros, P., Grosse-Kuntsleve, R.W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N.S., Read, R.J., et al. (1998). Crystallographic and NMR system: a new software system for macromolecular structure determination. Acta Crystallogr. D54, 905-921.
4. Carson, M. (1991). Ribbons 2.0. J. Appl. Crystallogr. 24, 958-961.
5. CCP4 (1994). The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D50, 760-763.
6. Charng, M.-J., Kinnunen, P., Hawker, J., Brand, T., and Schneider, M.D. (1996). FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor- β receptors. J. Biol. Chem. 277, 22941-22944.
7. Chen, R.-H., and Derynck, R. (1994). Homomeric interactions between type II transforming growth factor-β receptors. J. Biol. Chem. 269, 22868-22874.
8. Chen, F., and Weinberg, R.A. (1995). Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. Proc. Natl. Acad. Sci. USA 92, 15651569.
9. Chen, Y.-G., Liu, F., and Massagué, J. (1997). Mechanism of TGF-β receptor inhibition by FKBP12. EMBO J. 16, 3866-3876.
10. Chen, Y.-G., Hata, A., Lo, R.S., Wotton, D., Shi, Y., Pavletich, N., and Massagué, J. (1998). Determinants of specificity in TGF-β signal transduction. Genes Dev. 12, 2144-2152.
11. Feng, X.-H., and Derynck, R. (1997). A kinase subdomain of transforming growth factor-β (TGF-β) type I receptor determines the TGF-β intracellular signaling specificity. EMBO J. 16, 3912-3923.
12. Feng, X.-H., Filvaroff, E.H., and Derynck, R. (1995). Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. J. Biol. Chem. 270, 24237-24245.
13. Goldberg, J., Nairn, A.C., and Kuriyan, J. (1996). Structural basis for the autoinhibition of calcium/calmodulin-dependent protein kinase I. Cell 84, 875-887.
14. Griffith, J.P., Kim, J.L, Kim, E.E., Sintchak, M.D., Thomson, J.A., Fitzgibbon, M.J., Fleming, M.A., Caron, P.R., Hsiao, K., and Navia, M.A. (1995). X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell 82, 507-522.
15. Hanks, S.K., and Hunter, T. (1995). The eukaryotic protein kinase super-family: kinase (catalytic) domain structure and classification. FASEB J. 9, 576-596.
16. Harrison, R.K., and Stein, R.L. (1990). Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK506 binding protein: evidence for the existence of a family of distinct enzymes. Biochemistry 29, 3813-3816.
17. Heldin, C.H., Miyazono, K., and ten Dijke, P. (1997). TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
18. Henis, Y.I., Moustakas, A., Lin, H.Y., and Lodish, H.F. (1994). The type II and III transforming growth factor-β receptors form homooligomers. J. Cell. Biol. 726, 139-154.
19. Hu, S.-H., Parker, M.W., Lei, J.Y., Wilce, M.C.J., Benian, G.M., and Kemp, B.E. (1994). Insights into autoregulation from the crystal structure of twitchin kinase. Nature 369, 581-584.
20. Hubbard, S.R. (1997). Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 76, 5572-5581.
21. Hubbard, S.R., Wei, L, Ellis, L, and Hendrickson, W.A. (1994). Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372, 746-754.
22. Jeffrey, P.D., Russo, A.A., Polyak, K., Gibbs, E., Hurwitz, J., Massagué, J., and Pavletich, N.P. (1995). Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376, 313-320.
23. Johnson, L.N., Noble, M.E.M., and Owen, D.J. (1996). Active and inactive protein kinases: structural basis for regulation. Cell 85, 149-158.
24. Kleywegt, G.J., and Jones, T.A. (1993). Masks made easy. ESF/ CCP4 Newsletter, 56-59.
25. Kleywegt, G.J., and Read, R.J. (1998). Not your average density. Structure 5, 1557-1569.
26. Knighton, D.R., Zheng, J., Ten Eyck, L.F., Ashford, V.A., Xuong, N.-H., Taylor, S.S., and Sowadski, J.M. (1991). Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 407-414.
27. Kretzschmar, M., Liu, F., Hata, A., Doody, J., and Massagué, J. (1997). The BMP mediator Smadl is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev. 11, 984-995.
28. La Fortelle, E.D., and Bricogne, G. (1997). Maximum-likelihood heavy-atom parameter refinement in the MIR and MAD methods. Methods Enzymol. 276, 472-494.
29. Lawler, S., Feng, X.-H., Chen, R.-H., Maruoka, E.M., Turck, C.W., Griswold-Prenner, I., and Derynck, R. (1997). The type II transforming growth factor-β receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J. Biol. Chem. 272, 14850-14859.
30. Lindberg, R.A., Quinn, A.M., and Hunter, T. (1992). Dual-specificity kinases: will any hydroxyl do? Trends Biochem. Sci. 17, 114-119.
31. Livingston, C.D., and Barton, G.J. (1996). Identification of functional residues and secondary structure from protein multiple sequence alignment. Methods Enzymol. 266, 497-512.
32. Lu, G. (1999). FIND NCS: a program which automatically finds out the NCS operation from heavy atom sites, in press.
33. Luo, K., and Lodish, H.F. (1996). Signaling by chimeric erythropoietin-TGF-β receptors: homodimerization of the cytoplasmic domain of the type l TGF-β receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. EMBO J. 15, 4485-4496.
34. Massagué, J. (1990). The transforming growth factor-β family. Annu. Rev. Cell Biol. 6, 597-641.
35. Massagué , J. (1998). TGF-β signal transduction. Annu. Rev. Biochem. 67, 753-791.
36. Mohammadi, M., Schlessinger, J., and Hubbard, S.R. (1996). Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86, 577-587.
37. Nicholls, A., Sharp, K.A., and Honig, B. (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11, 281-296.
38. Okadome, T., Oeda, E., Saitoh, M., Ichijo, H., Moses, H.L., Miyazono, K., and Kawabata, M. (1996). Characterization of the interaction of FKBP12 with the transforming growth factor-β type I receptor in vivo. J. Biol. Chem. 277, 21687-21690.
39. Otwinowski, Z., and M inor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326.
40. Owen, D.J., Noble, M.E.M., Garman, E.F., Papageorgiou, A.C., and Johnson, L.N. (1995). Two structures of the catalytic domain of phosphorylase kinase: an active protein kinase complexed with substrate analogue and product. Structure 3, 467-482.
41. Roberts, A.B., and Sporn, M.B. (1990). The transforming growth factor-betas. In Peptide Growth Factors and Their Receptors, M.B. Sporn and A.B. Roberts, eds. (Heidelberg: Springer-Verlag), pp. 419-472.
42. Russo, A.A., Jeffrey, P.D., Patten, A.K., Massagué, J., and Pavletich, N.P. (1996). Crystal structure of the p27Kip1 cyclin-dependentkinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382, 325-331.
43. Schreiber, S.L (1991). Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 257, 283-287.
44. Shamu, C.E., and Walter, P. (1996). Oligomerization and phosphorylation of the Ire1 p kinase during intracellular signaling from the endoplasmic reticulum to the nucleus. EMBO J. 75, 3028-3039.
45. Shou, W., Aghdasi, B., Armstrong, D.L., Guo, Q., Bao, S., Charng, M.-J., Mathews, L.M., Schneider, M.D., Hamilton, S.L., and Matzuk, M.M. (1998). Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature 391, 489-492.
46. Sicher!, F., Moarefi, I., and Kuriyan, J. (1997). Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609.
47. Souchelnytskyi, S., ten Dijke, P., Miyazono, K., and Heldin, C.-H. (1996). Phosphorylation of Ser165 in TGF-β type I receptor modulates TGF-β1-induced cellular responses. EMBO J. 75, 6231-6240.
48. Stockwell, B.R., and Schreiber, S.L. (1998a). Probing the role of homomeric and heteromeric receptor interactions in TGF-β signaling using small molecule dimerizers. Curr. Biol. 8, 761-770.
49. Stockwell, B.R., and Schreiber, S.L. (1998b). TGF-β-signaling with small molecule FKBP12 antagonists that bind mylistoylated FKBP12-TGF-β-type I receptor fusion proteins. Chem. Biol. 5, 385-395.
50. Van Duyne, G.D., Standaert, R.F., Karplus, P.A., Schreiber, S.L, and Clardy, J. (1991). Atomic structure of FKBP-FK506, an immunophilinimmunosuppressant complex. Science 252, 839-842.
51. Wang, T., Donahoe, P.K., and Zervos, A.S. (1994). Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP12. Science 265, 674-676.
52. Wang, T., Li, B.-Y., Danielson, P.D., Shah, P.C., Rockwell, S., Lechleider, R.J., Martin, J., Manganaro, T., and Donahoe, P.K. (1996). The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors. Cell 86, 435-444.
53. Wang, Z., Harkins, P.C., Ulevitch, R.J., Man, J., Cobb, M.H., and Goldsmith, E.J. (1997). The structure of mitogen-activated protein kinase p38 at 2.1 Å resolution. Proc. Natl. Acad. Sci. USA 94, 2327-2332.
54. Weis-Garcia, F., and Massagué, J. (1996). Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J. 15, 276-289.
55. Wieser, R., Wrana, J.L., and Massagué, J. (1995). GS domain mutations that constitutively activate TβR-l, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14, 2199-2208.
56. Willis, S.A., Zimmerman, C.M., Li, L, and Mathews, L.S. (1996). Formation and activation by phosphorylation of activin receptor complexes. Mol. Endocrinol. 10, 367-379.
57. Wilson, K.P., Yamashita, M.M., Sintchak, M.D., Rotstein, S.H., Murcko, M.A., Boger, J., Thomson, U.A., Fitzgibbon, M.J., Black, U.R., and Navia, M.A. (1995). Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unligated form and in complex with FK506 and rapamycin. Acta Crystallogr. D51, 511-521.
58. Wrana, J.L., Attisano, L, Wieser, R., Ventura, F., and Massagué, J. (1994). Mechanism of activation of the TGF-β receptor. Nature 370, 341-347.
59. Xu, W., Harrison, S.C., and Eck, M.J. (1997). Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602.
60. Yamashita, H., ten Dijke, P., Franzen, P., Miyazano, K., and Heldin, C.-H. (1994). Formation of hetero-oligomeric complexes of type I and type II receptors foi transforming growth factor-β. J. Biol. Chem. 269, 20172-20178.
61. Zheng, J., Knighton, D.R., Ten Eyck, L.F., Karlsson, R., Xuong, N.-H., Taylor, S.S., and Sowadski, J.M. (1993). Crystal structure of the catalytic subunit of c-AMP-dependent protein kinase complexed with Mg/ATP and peptide inhibitor. Biochemistry 32, 2154-2161.